Phase 1b indibulin-capecitabine trial ended early after no dose-limiting toxicity seenSep 30Trial updateAlaunos Therapeutics, Inc.capecitabine
Results post for old USC gastric cancer trial; Bristol Myers Squibb opens new Zeposia PML studyJul 30Weekly roundup, 3 itemsBristol Myers Squibbiberdomide
Sign inSign in